483
Owen Biosciences Inc.Owen Biosciences Inc. – FDA 483, May 15, 2026
Record Details
Owen Biosciences Inc. in Baton Rouge, LA, a contract manufacturer of non-sterile OTC drug products, was cited for significant quality control deficiencies during an FDA inspection. The inspection revealed failures in preventing objectionable microorganisms, investigating out-of-specification results, and ensuring the overall adequacy of its quality system. These issues indicate a broad lack of adherence to good manufacturing practices.
View Company Profile
ID · c194332c-b426-4464-b761-f4e8e68c4af4
Other documents for Owen Biosciences Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.